Clinical Trials List
2018-12-01 - 2024-12-31
Phase III
Recruiting3
Terminated4
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳焜結 Division of Thoracic Medicine
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- James Chih-Hsin Yang Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- 林育麟 Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- Jih-Hsiang Lee 未分科
- 林宗哲 Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- YEN-TING LIN
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Hsien Li Division of Thoracic Medicine
- Tzu-Tao Chen Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
- Ching-Shan Luo Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
3 Recruiting
Audit
CRO
Co-Principal Investigator
- Yu-Min Yeh Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Po-Lan Su Division of Thoracic Medicine
- Shang-Yin Wu Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Chien-Chung Lin Division of Thoracic Medicine
- Wu-Chou Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Wei Chen Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- Chi-Lu Chiang 無
- 趙恒勝 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 枋岳甫 Division of Infectious Disease
- Wen-Cheng Chang Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- Jia-Shiuan Ju Division of Hematology & Oncology
- 邱立忠 Division of Thoracic Medicine
- Chih-Hsi Kuo Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- Cheng-Ta Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
34 participants
-
Global
360 participants
